Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naÃ¯ve patients-Reference-Cited by-同舟云学术

Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naÃ¯ve patients

Published:2010-02 Issue:2 Volume:11 Page:104-113
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:

Author:

Cicconi P,Cozzi-Lepri A,Castagna A,Trecarichi EM,Antinori A,Gatti F,Cassola G,Sighinolfi L,Castelli P,d'Arminio Monforte A,

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2009.00750.x/fullpdf

Reference20 articles.

1. 1â Deeks SG , Hecht FM , Swanson M et al. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. AIDS 1999; 13: F35âF43.

2. 2â Mocroft A , Phillips AN , Miller V et al. The use and response to second-line protease inhibitor regimens: results from the EuroSIDA Study. AIDS 2001; 15: 201â209.

3. 3â Hammer SM , Saag MS , Schechter M et al. International AIDS Society-USA panel. JAMA 2006; 296: 827â843.

4. 4â Vo TT , Ledergerber B , Keiser O et al. for the Swiss HIV Cohort Study. Durability and outcome of initial antiretroviral treatments received during 2000â2005 by patients in the Swiss HIV Cohort Study. J Infect Dis 2008; 197: 1685â1694.

5. 5â Braithwaite RS , Kozal MJ , Chang CC et al. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS 2007; 21: 1579â1589.

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns and preferences of people living with HIV starting or switching antiretroviral therapy: Real-world evidence from Portugal;International Journal of STD & AIDS;2024-07-25

2. Analysis of antiretroviral therapy interruption in people living with HIV during the 2010–2021 period;Farmacia Hospitalaria;2024-05

3. [Artículo traducido] Análisis de la interrupción de la terapia antirretroviral en personas que viven con VIH/sida durante el periodo 2010–2021;Farmacia Hospitalaria;2024-05

4. Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort;Journal of Antimicrobial Chemotherapy;2024-04-06

5. Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials;PLOS Global Public Health;2024-01-04